238 related articles for article (PubMed ID: 19653976)
1. A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression).
Shores MM; Kivlahan DR; Sadak TI; Li EJ; Matsumoto AM
J Clin Psychiatry; 2009 Jul; 70(7):1009-16. PubMed ID: 19653976
[TBL] [Abstract][Full Text] [Related]
2. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial.
Seidman SN; Spatz E; Rizzo C; Roose SP
J Clin Psychiatry; 2001 Jun; 62(6):406-12. PubMed ID: 11465516
[TBL] [Abstract][Full Text] [Related]
3. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
[TBL] [Abstract][Full Text] [Related]
4. Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.
Williams JW; Barrett J; Oxman T; Frank E; Katon W; Sullivan M; Cornell J; Sengupta A
JAMA; 2000 Sep; 284(12):1519-26. PubMed ID: 11000645
[TBL] [Abstract][Full Text] [Related]
5. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
6. Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial.
Seidman SN; Orr G; Raviv G; Levi R; Roose SP; Kravitz E; Amiaz R; Weiser M
J Clin Psychopharmacol; 2009 Jun; 29(3):216-21. PubMed ID: 19440073
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms.
Rabkin JG; Wagner GJ; Rabkin R
Arch Gen Psychiatry; 2000 Feb; 57(2):141-7; discussion 155-6. PubMed ID: 10665616
[TBL] [Abstract][Full Text] [Related]
8. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.
Barrett JE; Williams JW; Oxman TE; Frank E; Katon W; Sullivan M; Hegel MT; Cornell JE; Sengupta AS
J Fam Pract; 2001 May; 50(5):405-12. PubMed ID: 11350703
[TBL] [Abstract][Full Text] [Related]
9. The sexual effects of testosterone replacement in depressed men: randomized, placebo-controlled clinical trial.
Seidman SN; Roose SP
J Sex Marital Ther; 2006; 32(3):267-73. PubMed ID: 16809253
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
11. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
12. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
[TBL] [Abstract][Full Text] [Related]
13. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
[TBL] [Abstract][Full Text] [Related]
14. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
15. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
Leder BZ; Rohrer JL; Rubin SD; Gallo J; Longcope C
J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
[TBL] [Abstract][Full Text] [Related]
16. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
17. Testosterone and depression: systematic review and meta-analysis.
Zarrouf FA; Artz S; Griffith J; Sirbu C; Kommor M
J Psychiatr Pract; 2009 Jul; 15(4):289-305. PubMed ID: 19625884
[TBL] [Abstract][Full Text] [Related]
18. A Randomized Placebo-Controlled Trial of Low-Dose Testosterone Therapy in Women With Anorexia Nervosa.
Kimball A; Schorr M; Meenaghan E; Bachmann KN; Eddy KT; Misra M; Lawson EA; Kreiger-Benson E; Herzog DB; Koman S; Keane RJ; Ebrahimi S; Schoenfeld D; Klibanski A; Miller KK
J Clin Endocrinol Metab; 2019 Oct; 104(10):4347-4355. PubMed ID: 31219558
[TBL] [Abstract][Full Text] [Related]
19. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.
Shabsigh R; Kaufman JM; Steidle C; Padma-Nathan H
J Urol; 2004 Aug; 172(2):658-63. PubMed ID: 15247755
[TBL] [Abstract][Full Text] [Related]
20. Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2.
Wu F; Zitzmann M; Heiselman D; Donatucci C; Knorr J; Patel AB; Kinchen K
J Sex Med; 2016 Aug; 13(8):1212-9. PubMed ID: 27329542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
